Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AGA Medical Reaches Settlement With Justice Dept. Over Bribes In China

This article was originally published in PharmAsia News

Executive Summary

AGA Medical, a private firm that makes patent foramen ovale closure devices, agreed June 3 to immediately pay a $2 million criminal penalty under the Foreign Corrupt Practices Act (FCPA) and enter into a deferred prosecution agreement with the U.S. Department of Justice in connection with payments the company made to doctors in China

You may also be interested in...



Anti-Corruption Regs In China Should Be Warning Sign For Companies

The Chinese government's focus on corruption means device companies doing business there must redouble compliance efforts, according to Australia medical device lobbyist Anne Trimmer

Anti-Corruption Regs In China Should Be Warning Sign For Companies

The Chinese government's focus on corruption means device companies doing business there must redouble compliance efforts, according to Australia medical device lobbyist Anne Trimmer

China's Ministry Of Health Investigates More Than 1,000 Bribery Cases In 2007

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel